Tech Company Financing Transactions

VaxInnate Funding Round

VaxInnate, operating out of Cranbury, secured $40 million from Canaan Partners, New Leaf Venture Partners and CHL Medical Partners.

Transaction Overview

Company Name
Announced On
10/25/2006
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series C
Proceeds Purpose
The funds raised will be used for the continued development of the company's vaccines for human and avian flu, as well as vaccines for other prophylactic and therapeutic applications.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Cedar Brook Dr. 1
Cranbury, NJ 08512
USA
Email Address
Overview
VaxInnate is a privately-held biotechnology company developing novel, proprietary vaccines for both pandemic and seasonal influenza. The company's breakthrough vaccines are based on its Toll-like receptor (TLR) technology platform, which dramatically improves vaccine immunogenicity and efficacy.
Profile
VaxInnate LinkedIn Company Profile
Social Media
VaxInnate Company Twitter Account
Company News
VaxInnate News
Facebook
VaxInnate on Facebook
YouTube
VaxInnate on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Wayne Pisano
  Wayne Pisano LinkedIn Profile  Wayne Pisano Twitter Account  Wayne Pisano News  Wayne Pisano on Facebook
Chief Financial Officer
Kathleen McGowan
  Kathleen McGowan LinkedIn Profile  Kathleen McGowan Twitter Account  Kathleen McGowan News  Kathleen McGowan on Facebook
Chief Scientific Officer
Lynda Tussey
  Lynda Tussey LinkedIn Profile  Lynda Tussey Twitter Account  Lynda Tussey News  Lynda Tussey on Facebook
VP - Manufacturing
Bruce Weaver
  Bruce Weaver LinkedIn Profile  Bruce Weaver Twitter Account  Bruce Weaver News  Bruce Weaver on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/25/2006: GotVoice venture capital transaction
Next: 10/25/2006: EyeSpot venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary